Grant of License Option Sample Clauses

Grant of License Option. 3.01 Subject to rights of the United States under grants to UM and pursuant to 35 U.S.C. Section 201 et seq. and all implementing regulations, and subject to Section 3.02, UM grants to Company, and Company accepts, an exclusive worldwide license under Patent Rights to conduct research and development and to make, have made, use, lease, offer to sell, sell and import the Licensed Products within the Licensed Field as defined in Section 2.13 above, for the term of this Agreement. This license includes the right to grant sublicenses consistent with this Agreement. (a) UM specifically reserves the rights: 1. I. to practice, and permit UM Personnel and ISS to practice, under the Patent Rights, and to make and use the Licensed Products, and permit 1SS to make and use the Licensed Products, on a royalty-free basis solely for noncommercial research and education, and to license universities, colleges, and other noncommercial research or educational institutions to practice under the Patent Rights, and make and use the Licensed Products on a royalty-free basis solely for noncommercial research and education;

Grant of License Option. Voyager hereby grants to AbbVie an exclusive option, exercisable by AbbVie in its sole discretion during the License Option Period, to obtain the Exclusive License (the “License Option”).

Grant of License Option. For a period of ____ (__) days after the end of Filing Decision Period (such period, the “Option Period”), University hereby grants to XYZ a first option, without option fee other than the payments set forth in Section 4.01, (a) for XYZ and its Affiliates to acquire an exclusive, royalty bearing, worldwide license with the right to grant sublicenses, to develop, make, have made, use, offer for sale, sell and otherwise dispose of, products and methods practicing any University Invention or Joint Invention, and/or (b) for XYZ and its Affiliates to acquire a non-exclusive, royalty bearing, worldwide license with the right to grant sublicenses, to develop, make, have made, use, offer for sale, sell and otherwise dispose of, products and methods practicing University’s Background Technology (such option, the “License Option”). Upon XYZ’s request, University agrees to include into the License Option any computer software and its documentation falling under a University Copyright or Joint Copyright, if any (such computer software and documentation, collectively, the “Licensed Software”).

Grant of License Option. As consideration for Pfizer's performance of the Research Program and the payment by Pfizer to Peptide on the date of signing this Agreement of the total sum of one hundred and fifty thousand US dollars (US $150,000.00), during the term of this Agreement and for a period of six (6) months thereafter, Pfizer shall have the exclusive option to acquire an exclusive world-wide, royalty bearing, license, including the right to grant sub-licenses, to make, use, sell, offer for sale and import Products under all Peptide's right, title and interest in the Peptide Technology, Joint Technology and Joint Patent Rights in every country in the world. If Pfizer wishes to take up the option then the parties shall negotiate in good faith to reach agreement on the terms of the license which shall include the terms set forth in Exhibit C.

Grant of License Option. 3.01 Subject to rights of the United States under grants to UM and pursuant to 35 U.S.C. Section 201 et seq. and all implementing regulations, and subject to Section 3.02, UM grants to CDI, and CDI accepts, an exclusive worldwide license under Patent Rights to make, have made, use, lease, offer to sell, sell and import the Licensed Products within the Licensed Field for the term of this Agreement. This license includes the right to grant sublicenses constituent with this Agreement. 3.02 UM specifically reserves the rights: (a) to practice under the Patent Rights to make and use the Licensed Products on a royalty-free basis solely for research and education; (b) to provide information and material covered by the Patent Rights to universities, colleges and other research or educational institutions, but only for research and educational purposes and uses and not for any commercial purposes or uses; (c) to disseminate and publish the general scientific findings from research related to Patent Rights, provided that CDI has had the opportunity to review copies of all drafts relative to the use of Patent Rights within the Licensed Field prior to submission for publications, as set forth in Section 7.05 below; and (d) to license the Patent Rights for applications outside the Licensed Field. 3.03 CDI may transfer its rights to an Affiliate consistent with this Agreement, provided CDI is responsible for the obligations of its Affiliate relevant to this Agreement, including the payment of royalties, whether or not paid to CDI by its Affiliate. 3.04 CDI may grant sublicenses consistent with this Agreement, provided CDI is responsible for the obligations of its Sublicensees relevant to this Agreement as if the operations were carried out by CDI, including the payment of royalties, whether or not paid to CDI by its Affiliate. 3.05 CDI will identify its Affiliates and its Sublicensees under this Agreement to UM by name, address and field of sublicense(both as to geography and subject matter), and will promptly provide to UM a copy of each sublicense and a copy of each agreement or document designating or establishing an Affiliate having the right to use the Patent Rights. 3.06 The licenses granted under this Agreement do not confer any rights upon CDI by implication, estoppel, or otherwise as to any technology not specifically encompassed by Patent Rights, or any rights to use Patent Rights outside the Licensed Field. Joint Improvements and UM Improvements are not consi...

Grant of License Option. On the terms and subject to the ----------------------- conditions of this Agreement, Crescendo hereby grants to ALZA an option to obtain an exclusive license with respect to each Crescendo Product, exercisable on a product-by-product and country-by-country basis as described in Section 2.2.

Grant of License Option. 4 Article 4.

Grant of License Option. 3.1 ARADIGM hereby grants NOVO NORDISK a world-wide sole and exclusive license under the ARADIGM Patent Rights and ARADIGM Know-How a) to use, market, distribute, sell, offer for sale, import and export the Packaged Products and the Device in and from the Territory for use within the Field, with the right to sublicense, and b) to otherwise exercise and perform its rights and obligations under this Agreement. 3.2 ARADIGM hereby grants NOVO NORDISK the right to sublicense its customers to a) use the Packaged Products and the Device, and b) sell, offer to sell, import or export the Packaged Products and the Device, so long as said items were bought from NOVO NORDISK. 3.3 Notwithstanding the foregoing and except as set forth herein, effective one year after NOVO NORDISK gives ARADIGM the Alternative Technology Notice pursuant to Article 2.13, the licences granted to NOVO NORDISK under Article 3.1 and 3.2 will [...***...], and ARADIGM shall be entitled from and after receipt of the Alternative Technology Notice to * CONFIDENTIAL TREATMENT REQUESTED

Grant of License Option. On the terms and subject to the conditions of this Agreement, the Partnership hereby grants to ALZA a License Option for each Product.